Recent News

• 03.11.2025 - Barclays 27th Annual Global Healthcare Conference
• 03.11.2025 - Barclays 27th Annual Global Healthcare Conference
• 03.04.2025 - Catalyst Pharmaceuticals to Participate in the Barclays 27th Annual Global Healthcare Conference
• 03.04.2025 - Catalyst Pharmaceuticals to Participate in the Barclays 27th Annual Global Healthcare Conference
• 03.04.2025 - Catalyst Pharmaceuticals to Participate in the Barclays 27th Annual Global Healthcare Conference
• 02.27.2025 - Catalyst Pharmaceuticals Fourth Quarter and Full-Year 2024 Financial Results
• 02.27.2025 - Catalyst Pharmaceuticals Fourth Quarter and Full-Year 2024 Financial Results
• 02.26.2025 - Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
• 02.26.2025 - Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
• 02.26.2025 - Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Recent Filings

• 02.28.2025 - 3/A Initial statement of beneficial ownership of securities
• 02.26.2025 - 3 Initial statement of beneficial ownership of securities
• 02.26.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.26.2025 - EX-99.1 EX-99.1
• 02.26.2025 - 8-K Current report
• 02.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.19.2025 - 4 Statement of changes in beneficial ownership of securities